An investigation on behalf of investors in Pernix Therapeutics Holdings Inc (NASDAQ:PTX) shares over potential wrongdoing at Pernix Therapeutics Holdings was announced and NASDAQ:PTX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 10/26/2015 -- An investigation on for shareholders in NASDAQ:PTX shares was announced concerning potential breaches of fiduciary duties by certain Pernix Therapeutics Holdings directors.
Investors who purchased shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call 858-779-1554.
The investigation by a law firm concerns whether certain Pernix Therapeutics Holdings officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Pernix Therapeutics Holdings Inc reported that its annual Total Revenue rose from $84.87 million in 2013 to $121.75 million in 2014 and that its Net Loss increased from $25.64 million to $35.29 million. Shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) declined from $11.89 per share in March 2015 to as low as $2.59 per share on October 22, 2015.
Those who purchased shares of Pernix Therapeutics Holdings Inc have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com